Your browser does not support JavaScript
 
Saxenda Recommended for Approval By a Board of FDA Advisors
Posted By: 
Friday, July 11, 2014

Another medication Sterling Research is studying has been recommended for approval by a board of FDA advisors as a treatment for weight management. Liraglutide is already FDA approved for the treatment of Diabetes Mellitus Type 2.  It goes by the brand name Victoza.

When it is officially FDA approved, the weight loss therapy will marketed as Saxenda.  It will come as a 3mg dose, delivered subcutaneously.

Obesity is reaching epidemic proportions, and now patients worldwide will have another option in the battle against this disease. Thanks to all of our medical heroes that made this day possible!

-Matt Wenker MD



 

Blog Categories

  • News
    • 09/08/2017 - Gout Increasingly Common Among
    • 06/09/2017 - Understanding Fatty Liver
    • 03/28/2016 - Acne: More Than Just Pimples
    • 08/11/2015 - It's Coming...You Know It Is..
    • 02/10/2015 - Attorney General's Office Dema
    • 10/16/2014 - Regeneron, Sanofi drug slashes
    • 10/10/2014 - Ongoing Ebola Epidemic
    • 09/12/2014 - Contrave Approved by the FDA f
    • 07/11/2014 - Saxenda Recommended for Approv
    • 09/04/2013 - Only Half of Hypertensive Adul
  • Articles

Tag Cloud
 
 
Call for Participation
  Cincinnati / Mt. Auburn 
  Springdale 
Our Services
Patient Recruitment Specialist
Cincinnati, OH 

 (513) 621-5112
 (513) 621-5101
  2230 Auburn Avenue Level B 
Cincinnati, OH 45219 


 (513) 381-4100
 (513) 381-4120
  375 Glensprings Drive 2nd Flr
Cincinnati, OH 45246
 

 (513) 671-8080
 (513) 671-8090
About Us
Active Studies
Study Participants
About Clinical Trials
Sponsors/CROS
Blog
Careers

2020. STERLING RESEARCH. ALL RIGHTS RESERVED